Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)
113.01
+4.79 (4.43%)
Sep 30, 2025, 3:00 PM CST
SHA:688266 Market Cap
SHA:688266 has a market cap or net worth of 29.91 billion as of October 3, 2025. Its market cap has increased by 99.98% in one year.
Market Cap
29.91B
Enterprise Value
28.90B
Revenue
667.91M
Ranking
n/a
PE Ratio
n/a
Stock Price
113.01
Market Cap Chart
Since January 23, 2020, SHA:688266's market cap has increased from 17.90B to 29.91B, an increase of 67.11%. That is a compound annual growth rate of 9.44%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 30, 2025 | 29.91B | 81.37% |
Dec 31, 2024 | 16.49B | 17.70% |
Dec 29, 2023 | 14.01B | 40.02% |
Dec 30, 2022 | 10.01B | -29.08% |
Dec 31, 2021 | 14.11B | -9.10% |
Dec 31, 2020 | 15.53B | -13.27% |
Jan 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 476.78B |
WuXi AppTec | 328.32B |
Shenzhen Mindray Bio-Medical Electronics | 297.14B |
Sichuan Biokin Pharmaceutical | 150.50B |
Shanghai United Imaging Healthcare | 124.40B |
Zhangzhou Pientzehuang Pharmaceutical., | 118.73B |
Aier Eye Hospital Group | 114.71B |
Yunnan Baiyao Group Co.,Ltd | 101.26B |